I en klinisk undersøgelse hos patienter med metastaserende ikke- småcellet lungecancer (NSCLC) fik 2 patienter, der fik SUTENT, fatal pulmonalblødning.
Fatal pulmonary haemorrhage occurred in 2 patients receiving SUTENT on a clinical trial of patients with metastatic non-small cell lung cancer (NSCLC).